Virginia continues to see improvement as CMS tracks the use of antipsychotics for long-stay residents.  Virginia’s quarterly prevalence of antipsychotic use for long-stay residents is 15.2%; this is a 32.2% reduction since the fourth quarter of 2011. Virginia ranks 23^rd among the 50 states.

CMS tracks the progress of the National Partnership to Improve Dementia Care in Nursing Homes by reviewing publicly reported measures. The official measure of the Partnership is the percentage of long-stay nursing home residents who receive antipsychotic medication, excluding residents diagnosed with schizophrenia, Huntington’s disease or Tourette’s syndrome.fourth quarter of 2011, 23.9 percent residents received an antipsychotic medication; since then there has been a decrease of 35.4 percent to a national prevalence of 15.4 percent in the third quarter of 2017. Success varies by state and CMS region; some states and regions have a reduction greater than 35 percent. A four-quarter average of this measure is posted on the Nursing Home Compare website.

Additional Information

• Visit the Partnership webpage
• Send correspondence to dnh_behavioralhealth@cms.hhs.gov
• Register for the Medicare Learning Network call on March 20